Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
CRLCharles River Laboratories International	$9.07bn	55	n/a
PCVXVaxcyte	$8.97bn	n/a	n/a
IMGNImmunoGen	$8.72bn	n/a	n/a
NUVLNuvalent,	$8.46bn	n/a	n/a
BPMCBlueprint Medicines	$8.37bn	n/a	n/a
CYTKCytokinetics	$8.22bn	n/a	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a
IBRXImmunitybio	$7.92bn	n/a	n/a
MRUSMerus NV	$7.35bn	n/a	n/a
KYMRKymera Therapeutics	$7.16bn	n/a	n/a
CDTXCidara Therapeutics	$6.95bn	n/a	n/a
PTGXProtagonist Therapeutics	$6.76bn	n/a	n/a
ACLXArcellx	$6.73bn	n/a	n/a
RETAReata Pharmaceuticals	$6.52bn	n/a	n/a
BLTEBelite Bio	$6.51bn	n/a	n/a
CGONCG Oncology	$6.20bn	n/a	n/a
CNTACentessa Pharmaceuticals	$6.13bn	n/a	n/a
TERNTerns Pharmaceuticals	$6.08bn	n/a	n/a
COGTCogent Biosciences	$6.05bn	n/a	n/a
IMVTImmunovant	$5.96bn	n/a	n/a